(19)
(11) EP 1 207 869 A2

(12)

(88) Date of publication A3:
27.09.2001

(43) Date of publication:
29.05.2002 Bulletin 2002/22

(21) Application number: 00969253.4

(22) Date of filing: 29.08.2000
(51) International Patent Classification (IPC)7: A61K 31/136, A61P 31/10
(86) International application number:
PCT/EP0008/414
(87) International publication number:
WO 0115/684 (08.03.2001 Gazette 2001/10)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 31.08.1999 EP 99117111

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 

(72) Inventors:
  • SCHENKER, Rudolf
    CH-4312 Magden (CH)
  • STEIGER, Rolf, Franklin
    CH-4059 Basel (CH)
  • RYDER, Neil, Stewart
    A-1220 Wien (AT)
  • FROELICH, Olivier
    F-68680 Kembs (FR)

(74) Representative: Becker, Konrad et al
Novartis AGGeistiges Eigentum KonzernPatent- und Markenabteilung CHPostfach
4002 Basel
4002 Basel (CH)

   


(54) ANTIMYCOTIC DRUG